<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Polar Capital Global Healthcare Trust Plc — News on 6ix</title>
<link>https://6ix.com/company/polar-capital-global-healthcare-trust-plc</link>
<description>Latest news and press releases for Polar Capital Global Healthcare Trust Plc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Fri, 27 Mar 2026 13:03:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/polar-capital-global-healthcare-trust-plc" rel="self" type="application/rss+xml" />
<item>
<title>Net Asset Value(s)</title>
<link>https://6ix.com/company/polar-capital-global-healthcare-trust-plc/news/net-asset-values-271</link>
<guid isPermaLink="true">https://6ix.com/company/polar-capital-global-healthcare-trust-plc/news/net-asset-values-271</guid>
<pubDate>Fri, 27 Mar 2026 13:03:00 GMT</pubDate>
<description>Net Asset Value(s).</description>
</item>
<item>
<title>Factsheet</title>
<link>https://6ix.com/company/polar-capital-global-healthcare-trust-plc/news/factsheet-1</link>
<guid isPermaLink="true">https://6ix.com/company/polar-capital-global-healthcare-trust-plc/news/factsheet-1</guid>
<pubDate>Wed, 18 Mar 2026 12:21:00 GMT</pubDate>
<description>Polar Capital Global Healthcare Trust plc has published its latest monthly factsheet, which includes commentary from the Investment Manager. Investors can access this updated information on the company's website. The announcement does not contain any specific financial figures or performance data that would directly impact the stock share price at this time.
Disclaimer*</description>
</item>
<item>
<title>Issue of Equity</title>
<link>https://6ix.com/company/polar-capital-global-healthcare-trust-plc/news/issue-of-equity-225</link>
<guid isPermaLink="true">https://6ix.com/company/polar-capital-global-healthcare-trust-plc/news/issue-of-equity-225</guid>
<pubDate>Tue, 17 Mar 2026 17:24:00 GMT</pubDate>
<description>Polar Capital Global Healthcare Trust plc has sold 50,000 ordinary shares from its treasury for cash at 384.50 pence per share on 17 March 2026. Following this transaction, the total number of ordinary shares in issue is 124,149,256, with 24,784,256 shares remaining in treasury. The total voting rights attached to ordinary shares in issue are now 99,365,000, which shareholders should use as the denominator for calculating their notification obligations under the FCA's Disclosure Guidance and Tra</description>
</item>
<item>
<title>Transaction in Own Shares</title>
<link>https://6ix.com/company/polar-capital-global-healthcare-trust-plc/news/transaction-in-own-shares-625</link>
<guid isPermaLink="true">https://6ix.com/company/polar-capital-global-healthcare-trust-plc/news/transaction-in-own-shares-625</guid>
<pubDate>Mon, 16 Mar 2026 16:58:00 GMT</pubDate>
<description>Polar Capital Global Healthcare Trust plc has sold 100,000 ordinary shares from its treasury for cash at 384.60 pence per share on 16 March 2026. Following this transaction, the company has 124,149,256 ordinary shares in issue, with 24,834,256 remaining in treasury. The total voting rights attached to ordinary shares in issue now stand at 99,315,000, which shareholders should use as the denominator for calculating their notifiable interests under the FCA's Disclosure Guidance and Transparency Ru</description>
</item>
<item>
<title>Top Ten Equity Holdings and Exposures</title>
<link>https://6ix.com/company/polar-capital-global-healthcare-trust-plc/news/top-ten-equity-holdings-and-exposures-1</link>
<guid isPermaLink="true">https://6ix.com/company/polar-capital-global-healthcare-trust-plc/news/top-ten-equity-holdings-and-exposures-1</guid>
<pubDate>Wed, 04 Mar 2026 15:16:00 GMT</pubDate>
<description>Polar Capital Global Healthcare Trust plc has disclosed its top ten equity holdings and sector and geographic exposure as of February 27, 2026. The top ten holdings, representing 49.4% of the portfolio, are led by Eli Lilly & Co at 8.9%, followed by AstraZeneca at 6.3% and Roche at 5.7%. Sector exposure is dominated by Pharmaceuticals at 45.1% and Biotechnology at 23.5%, with the United States being the largest geographic allocation at 50.3%.
Disclaimer*</description>
</item>
<item>
<title>Holding(s) in Company</title>
<link>https://6ix.com/company/polar-capital-global-healthcare-trust-plc/news/holdings-in-company-863</link>
<guid isPermaLink="true">https://6ix.com/company/polar-capital-global-healthcare-trust-plc/news/holdings-in-company-863</guid>
<pubDate>Mon, 02 Mar 2026 16:39:00 GMT</pubDate>
<description>Rathbones Investment Management Ltd has reduced its holding in Polar Capital Global Healthcare Trust PLC, with its total voting rights now standing at 16.9259%, representing 16,685,536 shares. This is a decrease from its previous notification where it held 17.8611% of the voting rights. The change occurred on February 27, 2026, and was reported on March 2, 2026.
Disclaimer*</description>
</item>
<item>
<title>Total Voting Rights</title>
<link>https://6ix.com/company/polar-capital-global-healthcare-trust-plc/news/total-voting-rights-482</link>
<guid isPermaLink="true">https://6ix.com/company/polar-capital-global-healthcare-trust-plc/news/total-voting-rights-482</guid>
<pubDate>Mon, 02 Mar 2026 15:58:00 GMT</pubDate>
<description>Polar Capital Global Healthcare Trust plc has announced its total voting rights as of February 28, 2026. The company currently has 124,149,256 ordinary shares in issue, with 25,569,256 held in treasury, resulting in a total of 98,580,000 voting rights. This figure will serve as the denominator for shareholders calculating their notification obligations under the FCA's Disclosure Guidance and Transparency Rules.
Disclaimer*</description>
</item>
<item>
<title>Result of AGM</title>
<link>https://6ix.com/company/polar-capital-global-healthcare-trust-plc/news/result-of-agm-812</link>
<guid isPermaLink="true">https://6ix.com/company/polar-capital-global-healthcare-trust-plc/news/result-of-agm-812</guid>
<pubDate>Thu, 26 Feb 2026 16:22:00 GMT</pubDate>
<description>Polar Capital Global Healthcare Trust plc announced that all resolutions proposed at its Annual General Meeting on February 26, 2026, were passed on a poll. The company's issued share capital consists of 124,149,256 ordinary shares, with 25,754,256 held in treasury, resulting in 98,395,000 total voting rights, of which 40% were cast by proxy. Key resolutions, including the approval of the Annual Report and Financial Statements, Directors' Remuneration Policy and Implementation Report, re-electio</description>
</item>
<item>
<title>AGM Presentation</title>
<link>https://6ix.com/company/polar-capital-global-healthcare-trust-plc/news/agm-presentation-2</link>
<guid isPermaLink="true">https://6ix.com/company/polar-capital-global-healthcare-trust-plc/news/agm-presentation-2</guid>
<pubDate>Thu, 12 Feb 2026 16:31:00 GMT</pubDate>
<description>Polar Capital Global Healthcare Trust plc has uploaded the Investment Manager's pre-recorded audio presentation to its website ahead of the Annual General Meeting scheduled for 26 February 2026. This presentation, referencing information from the Company's Annual Report and Accounts for the year ended 30 September 2025, provides commentary on the healthcare sector. Shareholders are encouraged to submit questions regarding the formal business of the AGM [email protected], with the subjec</description>
</item>
<item>
<title>Register to receive PCGH Fact Sheets</title>
<link>https://6ix.com/company/polar-capital-global-healthcare-trust-plc/news/register-to-receive-pcgh-fact-sheets</link>
<guid isPermaLink="true">https://6ix.com/company/polar-capital-global-healthcare-trust-plc/news/register-to-receive-pcgh-fact-sheets</guid>
<pubDate>Thu, 29 Jan 2026 14:56:00 GMT</pubDate>
<description>Polar Capital Global Healthcare Trust plc is reminding investors that they can register to receive the Company's latest monthly factsheet, which includes the Investment Manager's commentary. This announcement does not contain any specific financial figures or performance data.
Disclaimer*</description>
</item>
<item>
<title>Dividend Declaration</title>
<link>https://6ix.com/company/polar-capital-global-healthcare-trust-plc/news/dividend-declaration-364</link>
<guid isPermaLink="true">https://6ix.com/company/polar-capital-global-healthcare-trust-plc/news/dividend-declaration-364</guid>
<pubDate>Wed, 14 Jan 2026 07:00:00 GMT</pubDate>
<description>Polar Capital Global Healthcare Trust plc has announced its second interim dividend of 1.00p per ordinary share, which will be paid on 27 February 2026 to shareholders on the register as of 6 February 2026, with shares trading ex-dividend from 5 February 2026.
Disclaimer*</description>
</item>
<item>
<title>Final Results</title>
<link>https://6ix.com/company/polar-capital-global-healthcare-trust-plc/news/final-results-496</link>
<guid isPermaLink="true">https://6ix.com/company/polar-capital-global-healthcare-trust-plc/news/final-results-496</guid>
<pubDate>Wed, 14 Jan 2026 07:00:00 GMT</pubDate>
<description>Polar Capital Global Healthcare Trust PLC reported a net asset value per ordinary share total return of -5.86% for the year ended 30 September 2025, outperforming its benchmark index by 1.95%. Total net assets decreased by 6.5% to £448,110,000, with net asset value per share falling to 369.51p. The company successfully implemented a tender offer and corporate reorganisation, with 22.47% of shares tendered and repurchased. Dividends declared for the year totalled 2.20p per ordinary share, a decre</description>
</item>
<item>
<title>Polar Capital Global Healthcare Trust Fact Sheets</title>
<link>https://6ix.com/company/polar-capital-global-healthcare-trust-plc/news/polar-capital-global-healthcare-trust-fact-sheets</link>
<guid isPermaLink="true">https://6ix.com/company/polar-capital-global-healthcare-trust-plc/news/polar-capital-global-healthcare-trust-fact-sheets</guid>
<pubDate>Thu, 08 Jan 2026 14:57:00 GMT</pubDate>
<description>Polar Capital Global Healthcare Trust plc is inviting investors to register to receive its latest monthly factsheets, which will include commentary from the Investment Manager. This announcement does not contain any specific financial figures or performance data.
Disclaimer*</description>
</item>
<item>
<title>Replacement: Holdings in Company</title>
<link>https://6ix.com/company/polar-capital-global-healthcare-trust-plc/news/replacement-holdings-in-company-21</link>
<guid isPermaLink="true">https://6ix.com/company/polar-capital-global-healthcare-trust-plc/news/replacement-holdings-in-company-21</guid>
<pubDate>Fri, 12 Dec 2025 14:55:00 GMT</pubDate>
<description>Polar Capital Global Healthcare Trust PLC announced an amendment to a previous holdings notification, updating the ISIN number for shares held by Canaccord Genuity Group Inc. and its controlled entities. This update reflects an acquisition or disposal of voting rights and an event changing the breakdown of voting rights, resulting in a total holding of 5.1846% of voting rights, equivalent to 4,879,607 shares, as of December 10, 2025. The change is attributed to a tender offer and a change in the</description>
</item>
<item>
<title>Sale of Ordinary Shares from Treasury</title>
<link>https://6ix.com/company/polar-capital-global-healthcare-trust-plc/news/sale-of-ordinary-shares-from-treasury</link>
<guid isPermaLink="true">https://6ix.com/company/polar-capital-global-healthcare-trust-plc/news/sale-of-ordinary-shares-from-treasury</guid>
<pubDate>Wed, 10 Dec 2025 16:55:00 GMT</pubDate>
<description>Polar Capital Global Healthcare Trust plc has sold 100,000 ordinary shares from its treasury for cash at 416.20 pence per share on December 10, 2025. Following this transaction, the company's total issued ordinary shares are 124,149,256, with 30,032,282 shares remaining in treasury. The total voting rights attached to ordinary shares in issue now stand at 94,116,974, which shareholders should use as the denominator for calculating their notification obligations under the FCA's Disclosure Guidanc</description>
</item>
<item>
<title>Transactions in a Closed Period</title>
<link>https://6ix.com/company/polar-capital-global-healthcare-trust-plc/news/transactions-in-a-closed-period-1</link>
<guid isPermaLink="true">https://6ix.com/company/polar-capital-global-healthcare-trust-plc/news/transactions-in-a-closed-period-1</guid>
<pubDate>Mon, 08 Dec 2025 11:24:00 GMT</pubDate>
<description>Polar Capital Global Healthcare Trust plc has confirmed that all inside information has been previously published or notified via a regulatory information service, and its net asset value per share is announced daily. Consequently, the company is not prohibited from dealing in its own securities during the current closed period, which will end around January 5, 2026, with the announcement of its annual results for the year ended September 30, 2025. The company will notify a regulatory informatio</description>
</item>
<item>
<title>Director/PDMR Shareholding</title>
<link>https://6ix.com/company/polar-capital-global-healthcare-trust-plc/news/directorpdmr-shareholding-792</link>
<guid isPermaLink="true">https://6ix.com/company/polar-capital-global-healthcare-trust-plc/news/directorpdmr-shareholding-792</guid>
<pubDate>Thu, 04 Dec 2025 10:00:00 GMT</pubDate>
<description>Polar Capital Global Healthcare Trust plc announced that Caroline Gulliver, a Non-executive Director, purchased 10,000 Ordinary Shares at 422.869 pence per share on December 2, 2025, for a total of £42,286.90. Following this transaction, Ms. Gulliver now holds 10,000 Ordinary Shares, representing approximately 0.01% of the company's issued share capital.
Disclaimer*</description>
</item>
<item>
<title>Tender Price</title>
<link>https://6ix.com/company/polar-capital-global-healthcare-trust-plc/news/tender-price-1</link>
<guid isPermaLink="true">https://6ix.com/company/polar-capital-global-healthcare-trust-plc/news/tender-price-1</guid>
<pubDate>Mon, 01 Dec 2025 09:36:00 GMT</pubDate>
<description>Polar Capital Global Healthcare Trust plc has announced the Tender Price for its share repurchase program, set at 425.61 pence per Ordinary Share, reflecting the Net Asset Value per Share as of November 27, 2025, less tender offer expenses. Of the 121,270,000 shares eligible for tender, 27,253,026 shares, representing 22.47% of the issued share capital, were validly tendered. These repurchased shares will be held in treasury and are available for reissue from December 2, 2025, potentially at a p</description>
</item>
<item>
<title>Result of General Meeting</title>
<link>https://6ix.com/company/polar-capital-global-healthcare-trust-plc/news/result-of-general-meeting-241</link>
<guid isPermaLink="true">https://6ix.com/company/polar-capital-global-healthcare-trust-plc/news/result-of-general-meeting-241</guid>
<pubDate>Thu, 27 Nov 2025 11:25:00 GMT</pubDate>
<description>Polar Capital Global Healthcare Trust plc announced that all three resolutions proposed at its General Meeting were passed, including a tender offer for up to 100% of its ordinary shares, amendments to extend the company's life indefinitely with subsequent five-yearly tenders, and authorization to reissue treasury shares below net asset value but above the tender price. The total voting rights were 121,270,000, with 55.9% of these voted in the poll, and the tender offer resolution passed with 92</description>
</item>
<item>
<title>Result of Tender Offer</title>
<link>https://6ix.com/company/polar-capital-global-healthcare-trust-plc/news/result-of-tender-offer-33</link>
<guid isPermaLink="true">https://6ix.com/company/polar-capital-global-healthcare-trust-plc/news/result-of-tender-offer-33</guid>
<pubDate>Wed, 26 Nov 2025 07:00:00 GMT</pubDate>
<description>Polar Capital Global Healthcare Trust plc announced the results of its Tender Offer, where 27,253,026 ordinary shares, representing 22.47% of the issued share capital excluding treasury shares, were validly tendered. The company confirmed it met the minimum continuation condition, with nearly 80% of existing shareholders remaining invested, which is viewed as a strong endorsement amidst industry challenges. The company expressed confidence in the positive outlook for the healthcare sector and th</description>
</item>
</channel>
</rss>